ClinicalTrials.govpublic full text
Magnesium Supplementation in People With XMEN Syndrome
xmen, neoplasia, magnesium transporter 1 (magt1), primary immunodeficiency, x-linked immunodeficiency, epstein-barr virus (ebv) infection, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 917586
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.